Miller Mary — SEC Form 4 filings
SEC reporting owner CIK 1841088. 29 Form 4 filings on record with FilingPulse; latest filed 2026-08-20.
Transaction summary — filings shown
Covers all 29 filings on record, filed 2024-01-19 to 2026-08-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 758 shares, $1,380 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 27.
- Largest priced transaction: sale of 573 shares @ $1.76 ($1,008) in Acrivon Therapeutics, Inc., filed 2026-07-23.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Acrivon Therapeutics, Inc. (ACRV) | Chief Legal Officer | 29 | — | 2 legs · 758 sh · $1,380 | 27 |
Form 4 filings — Miller Mary
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-20 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Sale (S): 185 @ $2.01 | EDGAR |
| 2026-07-23 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Sale (S): 573 @ $1.76 | EDGAR |
| 2026-05-20 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Grant/award (A): 49,830 @ $0 | EDGAR |
| 2026-05-18 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Tax withholding (F): 184 @ $1.92 | EDGAR |
| 2026-04-21 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Tax withholding (F): 558 @ $1.78 | EDGAR |
| 2026-03-03 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Grant/award (A): 129,760 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Tax withholding (F): 217 @ $1.63 | EDGAR |
| 2026-01-21 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Tax withholding (F): 659 @ $1.98 | EDGAR |
| 2025-11-18 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Tax withholding (F): 184 @ $2.24 | EDGAR |
| 2025-10-21 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Tax withholding (F): 558 @ $1.81 | EDGAR |
| 2025-10-03 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Tax withholding (F): 284 @ $1.81 | EDGAR |
| 2025-08-18 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Tax withholding (F): 184 @ $1.39 | EDGAR |
| 2025-07-21 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Tax withholding (F): 558 @ $1.32 | EDGAR |
| 2025-05-16 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Tax withholding (F): 184 @ $1.14 | EDGAR |
| 2025-04-18 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Tax withholding (F): 558 @ $1.81 | EDGAR |
| 2025-04-03 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Grant/award (A): 15,616 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Grant/award (A): 93,693 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Tax withholding (F): 217 @ $5.42 | EDGAR |
| 2025-01-22 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Tax withholding (F): 659 @ $5.78 | EDGAR |
| 2024-11-27 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Grant/award (A): 67,567 (derivative) @ $0 | EDGAR |
| 2024-11-18 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Tax withholding (F): 184 @ $7.92 | EDGAR |
| 2024-10-21 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Tax withholding (F): 558 @ $7.87 | EDGAR |
| 2024-10-03 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Tax withholding (F): 284 @ $6.98 | EDGAR |
| 2024-08-16 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Tax withholding (F): 184 @ $7.02 | EDGAR |
| 2024-07-19 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Tax withholding (F): 558 @ $7.69 | EDGAR |
| 2024-05-16 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Tax withholding (F): 184 @ $8.36 | EDGAR |
| 2024-04-19 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Tax withholding (F): 558 @ $10.34 | EDGAR |
| 2024-02-16 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Tax withholding (F): 217 @ $3.40 | EDGAR |
| 2024-01-19 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Tax withholding (F): 652 @ $4.35 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1841088 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →